-The Telegraph Swiss Pharma company Novartis today told the Supreme Court that if it gets an Indian patent on its anti-cancer drug Glivec, it would continue giving free drugs to 85 per cent patients till 2018 provided prices were left untouched. But the court described its scheme of classifying people on the basis of their incomes as “too complicated” and again urged the company to reduce prices. Whatever the scheme, the end result...

-PTI Pharma firm Biological E Limited (BEL) today launched the country's first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease. The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here. "The vaccine, which will also be exported, has good...

-The Hindu The Jan Swasthya Abhiyan on Monday called upon the Union Government to extend free medicine supply scheme, presently operational in a few States like Rajasthan and Tamil Nadu, all over the country to reduce out-of-pocket expenditure of common people on health care. Such a scheme would especially benefit the patients deprived of any kind of treatment due to poverty. In a letter addressed to Union Health & Family Welfare Secretary...

-Live Mint Cipla Ltd won a landmark patent case against Swiss drug maker F Hoffmann-La Roche Ltd in the Delhi high court on Friday over the Indian company’s generic copy of lung cancer drug Tarceva after a four-year court battle. Justice Manmohan Singh observed in his 280-page judgement that it had been scientifically proven that Cipla’s generic version was a polymorph B variant of Roche’s patented drug and that it didn’t actually...

-The Economic Times India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country. The National Pharmaceutical Pricing Authority (NPPA) has written to the department of pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET. The amendment will allow NPPA to seek details of the methodology adopted...